Acute‐phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF‐κB–dependent signal transduction pathway
Open Access
- 29 December 2005
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (1), 105-114
- https://doi.org/10.1002/art.21518
Abstract
Objective To examine the role of the acute-phase protein serum amyloid A (A-SAA) in regulating cell adhesion molecule expression, leukocyte recruitment, and angiogenesis in rheumatoid arthritis (RA). Methods Intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and matrix metalloproteinase 1 (MMP-1) expression was examined in RA fibroblast-like synoviocytes (FLS) and human microvascular endothelial cells (HMVECs) using flow cytometry and enzyme-linked immunosorbent assay techniques. Peripheral blood mononuclear cell (PBMC) adhesion to FLS/HMVECs was determined by flow cytometry. Angiogenesis was examined using a Boyden chemotaxis chamber and Matrigel tubule formation. NF-κB/IκBα mediation of the effects of A-SAA was investigated using a specific NF-κB inhibitor and Western blotting. Results A-SAA significantly enhanced the time- and dose-dependent expression of ICAM-1 and VCAM-1 as effectively as interleukin-1β/tumor necrosis factor α. A-SAA promoted the adhesion of PBMCs to FLS and HMVECs. In addition, A-SAA at 10 μg/ml and 50 μg/ml significantly increased endothelial cell tube formation by 69% and 207%, respectively. At 50 μg/ml and 100 μg/ml, A-SAA increased HMVEC migration by 188 ± 54% and 296 ± 71%, respectively (mean ± SEM). A-SAA–induced expression of VCAM-1, ICAM-1, and MMP-1 was down-regulated by NF-κB inhibition. Furthermore, A-SAA induced IκBα degradation and NF-κB translocation, suggesting that its proinflammatory effects are mediated in part by NF-κB signaling. Conclusion Our findings demonstrate the ability of A-SAA to induce adhesion molecule expression, angiogenesis, and matrix degradation, mechanisms that are mediated by NF-κB. Targeting A-SAA and its signaling pathways may represent a new therapeutic approach in the treatment of RA.Keywords
This publication has 46 references indexed in Scilit:
- Local expression of the serum amyloid A and formyl peptide receptor–like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritisArthritis & Rheumatism, 2004
- Angiogenesis as a target in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2003
- A Novel Role for Interleukin-18 in Adhesion Molecule Induction through NFκB and Phosphatidylinositol (PI) 3-Kinase-dependent Signal Transduction PathwaysOnline Journal of Public Health Informatics, 2001
- Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2001
- Acute-Phase Proteins and Other Systemic Responses to InflammationThe New England Journal of Medicine, 1999
- Cell Adhesion Molecules in Rheumatoid ArthritisDrugs & Aging, 1996
- Adhesion molecules in rheumatoid arthritis: role in the pathogenesis and prospects for therapy.Annals Of The Rheumatic Diseases, 1994
- The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A proteinImmunology Today, 1994
- Evolution of the Serum Amyloid A (SAA) Protein SuperfamilyGenomics, 1994
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988